Salvage Stereotactic Reirradiation With or Without Cetuximab for Locally Recurrent Head-and-Neck Cancer: A Feasibility Study
- 1 September 2012
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 84 (1), 203-209
- https://doi.org/10.1016/j.ijrobp.2011.11.054
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck CarcinomaJournal of Clinical Oncology, 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckHead & Neck, 2007
- Salvage Re-Irradiation for Recurrent Head and Neck CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinomaHead & Neck, 2006
- Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinomaHead & Neck, 2002
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI Journal of the National Cancer Institute, 1996